Literature DB >> 11140839

Sudden death caused by pulmonary thromboembolism in Proteus syndrome.

A M Slavotinek1, S J Vacha, K F Peters, L G Biesecker.   

Abstract

We report 3 patients with Proteus syndrome (PS) who died suddenly from pulmonary embolism (PE). The first patient was a male diagnosed with PS at 12 years who had varicose veins, portal vein thrombosis, right iliac vein occlusion and recurrent PE. At age 25 years, he was admitted to the hospital with a severe headache. Despite therapeutic doses of warfarin, investigations for an acute episode of breathlessness showed PE and he was unable to be resuscitated. The second case was a 9-year-old male with PS who collapsed at home and could not be revived. Autopsy revealed that the cause of death was a PE associated with thrombosis of the deep veins (DVT). The third patient was a 17-year-old female undergoing inpatient treatment for sinusitis when she unexpectedly arrested. She could not be revived and a full autopsy revealed a large PE with no identified DVT. We conclude that PE is a serious complication of PS and recommend vigilance concerning the signs and symptoms of thrombosis and PE in individuals with PS, including children. Aggressive evaluation and treatment should be considered urgently in patients with PS and signs or symptoms of DVT.

Entities:  

Mesh:

Year:  2000        PMID: 11140839     DOI: 10.1034/j.1399-0004.2000.580509.x

Source DB:  PubMed          Journal:  Clin Genet        ISSN: 0009-9163            Impact factor:   4.438


  14 in total

1.  Characterization of thrombosis in patients with Proteus syndrome.

Authors:  Kim M Keppler-Noreuil; Jay N Lozier; Julie C Sapp; Leslie G Biesecker
Journal:  Am J Med Genet A       Date:  2017-06-19       Impact factor: 2.802

2.  Assessment and management of the orthopedic and other complications of Proteus syndrome.

Authors:  Laura L Tosi; Julie C Sapp; Elizabeth S Allen; Regis J O'Keefe; Leslie G Biesecker
Journal:  J Child Orthop       Date:  2011-05-28       Impact factor: 1.548

3.  A mosaic activating mutation in AKT1 associated with the Proteus syndrome.

Authors:  Marjorie J Lindhurst; Julie C Sapp; Jamie K Teer; Jennifer J Johnston; Erin M Finn; Kathryn Peters; Joyce Turner; Jennifer L Cannons; David Bick; Laurel Blakemore; Catherine Blumhorst; Knut Brockmann; Peter Calder; Natasha Cherman; Matthew A Deardorff; David B Everman; Gretchen Golas; Robert M Greenstein; B Maya Kato; Kim M Keppler-Noreuil; Sergei A Kuznetsov; Richard T Miyamoto; Kurt Newman; David Ng; Kevin O'Brien; Steven Rothenberg; Douglas J Schwartzentruber; Virender Singhal; Roberto Tirabosco; Joseph Upton; Shlomo Wientroub; Elaine H Zackai; Kimberly Hoag; Tracey Whitewood-Neal; Pamela G Robey; Pamela L Schwartzberg; Thomas N Darling; Laura L Tosi; James C Mullikin; Leslie G Biesecker
Journal:  N Engl J Med       Date:  2011-07-27       Impact factor: 91.245

4.  Precapillary pulmonary arterial hypertension in a patient with Proteus syndrome.

Authors:  Akash Mathavan; Akshay Mathavan; Cyrus Vahdatpour; Christina Eagan; Saminder Singh Kalra; Ali Ataya
Journal:  Pulm Circ       Date:  2022-04-01       Impact factor: 2.886

5.  Characterization of the hepatosplenic and portal venous findings in patients with Proteus syndrome.

Authors:  Varun Takyar; Divya Khattar; Alexander Ling; Rachna Patel; Julie C Sapp; Sun A Kim; Sungyoung Auh; Leslie G Biesecker; Kim M Keppler-Noreuil; Theo Heller
Journal:  Am J Med Genet A       Date:  2018-10-22       Impact factor: 2.802

6.  Mutations of AKT3 are associated with a wide spectrum of developmental disorders including extreme megalencephaly.

Authors:  Diana Alcantara; Andrew E Timms; Karen Gripp; Laura Baker; Kaylee Park; Sarah Collins; Chi Cheng; Fiona Stewart; Sarju G Mehta; Anand Saggar; László Sztriha; Melinda Zombor; Oana Caluseriu; Ronit Mesterman; Margot I Van Allen; Adeline Jacquinet; Sofia Ygberg; Jonathan A Bernstein; Aaron M Wenger; Harendra Guturu; Gill Bejerano; Natalia Gomez-Ospina; Anna Lehman; Enrico Alfei; Chiara Pantaleoni; Valerio Conti; Renzo Guerrini; Ute Moog; John M Graham; Robert Hevner; William B Dobyns; Mark O'Driscoll; Ghayda M Mirzaa
Journal:  Brain       Date:  2017-10-01       Impact factor: 13.501

7.  Proteus syndrome: A medical rarity.

Authors:  Chandni Sinha; Babita Gupta; Manpreet Kaur; Ajeet Kumar; Chandan Kumar Dey
Journal:  Saudi J Anaesth       Date:  2011-04

8.  Prophylactic anticoagulation of individuals with Proteus syndrome and COVID-19.

Authors:  Christopher A Ours; Leslie G Biesecker
Journal:  Am J Med Genet A       Date:  2020-09-10       Impact factor: 2.578

9.  Repression of AKT signaling by ARQ 092 in cells and tissues from patients with Proteus syndrome.

Authors:  Marjorie J Lindhurst; Miranda R Yourick; Yi Yu; Ronald E Savage; Dora Ferrari; Leslie G Biesecker
Journal:  Sci Rep       Date:  2015-12-11       Impact factor: 4.379

10.  Thrombosis risk factors in PIK3CA-related overgrowth spectrum and Proteus syndrome.

Authors:  Kim M Keppler-Noreuil; Jay Lozier; Neal Oden; Anjali Taneja; Jasmine Burton-Akright; Julie C Sapp; Leslie G Biesecker
Journal:  Am J Med Genet C Semin Med Genet       Date:  2019-09-06       Impact factor: 3.359

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.